RankingsPricing
  1. JP-listed companies
  2. Carna Biosciences, Inc.
  3. Financials
  4. Stockholders' equity

Carna Biosciences, Inc.JP:4572

Market cap
¥7.7B
P/E ratio
-3.6x
SummaryFinancialsHistorySegmentsOwnershipWorkforce
Period EndStockholders' equity (Million JPY)YoY (%)
Dec 31, 20242,475-36.16%
Dec 31, 20233,878+6.47%
Dec 31, 20223,642-15.61%
Dec 31, 20214,316+12.85%
Dec 31, 20203,824-0.77%
Dec 31, 20193,854+334.22%
Dec 31, 2018887-35.59%
Dec 31, 20171,378-20.78%
Dec 31, 20161,739-7.01%
Dec 31, 20151,871+125.30%
Dec 31, 2014830-48.04%
Dec 31, 20131,598

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)